551 related articles for article (PubMed ID: 28720071)
1. Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease.
Arena A; Iyer AM; Milenkovic I; Kovacs GG; Ferrer I; Perluigi M; Aronica E
Curr Alzheimer Res; 2017; 14(12):1305-1317. PubMed ID: 28720071
[TBL] [Abstract][Full Text] [Related]
2. Metabotropic glutamate receptor 5 in Down's syndrome hippocampus during development: increased expression in astrocytes.
Iyer AM; van Scheppingen J; Milenkovic I; Anink JJ; Lim D; Genazzani AA; Adle-Biassette H; Kovacs GG; Aronica E
Curr Alzheimer Res; 2014; 11(7):694-705. PubMed ID: 25115540
[TBL] [Abstract][Full Text] [Related]
3. Integrated miRNA and mRNA expression profiling in fetal hippocampus with Down syndrome.
Shi WL; Liu ZZ; Wang HD; Wu D; Zhang H; Xiao H; Chu Y; Hou QF; Liao SX
J Biomed Sci; 2016 Jun; 23(1):48. PubMed ID: 27266699
[TBL] [Abstract][Full Text] [Related]
4. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
[TBL] [Abstract][Full Text] [Related]
5. miR-146a polymorphism influences levels of miR-146a, IRAK-1, and TRAF-6 in young patients with coronary artery disease.
Ramkaran P; Khan S; Phulukdaree A; Moodley D; Chuturgoon AA
Cell Biochem Biophys; 2014 Mar; 68(2):259-66. PubMed ID: 23794009
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-574 is involved in cognitive impairment in 5-month-old APP/PS1 mice through regulation of neuritin.
Li F; Wei G; Bai Y; Li Y; Huang F; Lin J; Hou Q; Deng R; Zhou JH; Zhang SX; Chen DF
Brain Res; 2015 Nov; 1627():177-88. PubMed ID: 26423933
[TBL] [Abstract][Full Text] [Related]
7. Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology.
Sierksma A; Lu A; Salta E; Vanden Eynden E; Callaerts-Vegh Z; D'Hooge R; Blum D; Buée L; Fiers M; De Strooper B
Mol Neurodegener; 2018 Oct; 13(1):54. PubMed ID: 30314521
[TBL] [Abstract][Full Text] [Related]
8. Mice with miR-146a deficiency develop severe gouty arthritis via dysregulation of TRAF 6, IRAK 1 and NALP3 inflammasome.
Zhang QB; Qing YF; Yin CC; Zhou L; Liu XS; Mi QS; Zhou JG
Arthritis Res Ther; 2018 Mar; 20(1):45. PubMed ID: 29544526
[TBL] [Abstract][Full Text] [Related]
9. Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy.
Aronica E; Fluiter K; Iyer A; Zurolo E; Vreijling J; van Vliet EA; Baayen JC; Gorter JA
Eur J Neurosci; 2010 Mar; 31(6):1100-7. PubMed ID: 20214679
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response.
Iyer A; Zurolo E; Prabowo A; Fluiter K; Spliet WG; van Rijen PC; Gorter JA; Aronica E
PLoS One; 2012; 7(9):e44789. PubMed ID: 23028621
[TBL] [Abstract][Full Text] [Related]
11. microRNA 155 up regulation in the CNS is strongly correlated to Down's syndrome dementia.
Tili E; Mezache L; Michaille JJ; Amann V; Williams J; Vandiver P; Quinonez M; Fadda P; Mikhail A; Nuovo G
Ann Diagn Pathol; 2018 Jun; 34():103-109. PubMed ID: 29661714
[TBL] [Abstract][Full Text] [Related]
12. miR-146a-mediated suppression of the inflammatory response in human adipocytes.
Roos J; Enlund E; Funcke JB; Tews D; Holzmann K; Debatin KM; Wabitsch M; Fischer-Posovszky P
Sci Rep; 2016 Dec; 6():38339. PubMed ID: 27922090
[TBL] [Abstract][Full Text] [Related]
13. Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis.
Griffin WS; Sheng JG; McKenzie JE; Royston MC; Gentleman SM; Brumback RA; Cork LC; Del Bigio MR; Roberts GW; Mrak RE
Neurobiol Aging; 1998; 19(5):401-5. PubMed ID: 9880042
[TBL] [Abstract][Full Text] [Related]
14. microRNAs expression correlates with levels of APP, DYRK1A, hyperphosphorylated Tau and BDNF in the hippocampus of a mouse model for Down syndrome during ageing.
Chaves JCS; Machado FT; Almeida MF; Bacovsky TB; Ferrari MFR
Neurosci Lett; 2020 Jan; 714():134541. PubMed ID: 31605772
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid.
Müller M; Kuiperij HB; Claassen JA; Küsters B; Verbeek MM
Neurobiol Aging; 2014 Jan; 35(1):152-8. PubMed ID: 23962497
[TBL] [Abstract][Full Text] [Related]
16. mTOR Hyperactivation in down syndrome hippocampus appears early during development.
Iyer AM; van Scheppingen J; Milenkovic I; Anink JJ; Adle-Biassette H; Kovacs GG; Aronica E
J Neuropathol Exp Neurol; 2014 Jul; 73(7):671-83. PubMed ID: 24918639
[TBL] [Abstract][Full Text] [Related]
17. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.
Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH
Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374
[TBL] [Abstract][Full Text] [Related]
18. Whether Alzheimer's diseases related genes also differently express in the hippocampus of Ts65Dn mice?
Zhang B; Wang Q; Miao T; Yu B; Yuan P; Kong J; Lu B
Int J Clin Exp Pathol; 2015; 8(4):4120-5. PubMed ID: 26097601
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide miR-155 and miR-802 target gene identification in the hippocampus of Ts65Dn Down syndrome mouse model by miRNA sponges.
Bofill-De Ros X; Santos M; Vila-Casadesús M; Villanueva E; Andreu N; Dierssen M; Fillat C
BMC Genomics; 2015 Nov; 16():907. PubMed ID: 26546125
[TBL] [Abstract][Full Text] [Related]
20. Differences in beta-amyloid (beta/A4) deposition in human patients with Down's syndrome and sporadic Alzheimer's disease.
Armstrong RA
Neurosci Lett; 1994 Mar; 169(1-2):133-6. PubMed ID: 8047269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
